In this edition of the Motley Fool's health-care show Market Checkup, analysts David Williamson and Max Macaluso look at the big pharma companies circling biotech ViroPharma, a cancer drug granted priority review by the FDA, and a serious patent issue that affects fish oil drugmakers GlaxoSmithKline and Amarin.